Preventive Medicine: What to Check and What to Skip

Good prevention looks less like a catalogue of tests and more like a useful conversation. What worries you? What runs in your family? Which risk deserves attention now? Most importantly, what would we do differently if a result were high, low or normal?

Preventive medicine aims to stop disease, find it while treatment can still help and reduce its consequences. Its sensible version does not promise complete control. It sets priorities and also protects people from medical excess.

What prevention really means

Prevention is usually divided into levels. Primary prevention acts before disease appears, for example through vaccination, physical activity or stopping smoking. Secondary prevention looks for silent disease with validated screening. Tertiary prevention reduces complications once a diagnosis exists. Quaternary prevention avoids harm from unnecessary tests, labels or treatments.

That final level matters in longevity care. A healthy person can complete a huge panel and receive several out-of-range results by chance alone. If every finding triggers another test, a preventive visit may create a problem that would never have affected that person's life.

The population context supports action, but not indiscriminate testing. The World Health Organization estimates that noncommunicable diseases caused at least 43 million deaths in 2021. Tobacco, inactivity, harmful alcohol use, unhealthy diets and air pollution drive a substantial share of risk. None requires an exotic test before action can begin.

A practical order for your review

There is no universal blood panel for everyone. There is a sensible hierarchy. This table starts with high-value decisions and saves specific tests for a real question.

First layer	What to review	What it can change
History and context	Family history, diagnoses, medication, pregnancy, symptoms and mental health	Defines prior risk and prevents isolated-number medicine
Habits and environment	Tobacco, alcohol, food, movement, sleep, work and social support	Finds large levers that blood work cannot show
Cardiometabolic health	Repeated blood pressure, lipids, glucose or HbA1c, kidney function and waist when relevant	Guides habits, follow-up and medical treatment when needed
Specific protection	Vaccines and cancer screening by official programme, age and risk	Prevents infection or finds disease during a useful window
Function	Strength, mobility, falls, aerobic capacity and body composition when informative	Prioritises strength, activity, recovery or further assessment

For a closer look at laboratory data, our longevity biomarkers guide explains what each family of measurements can add. The same rule applies: a number is useful when it changes a decision and comes from a method that can be interpreted reliably.

Screening is not diagnosis

Screening is offered to people without symptoms to find disease or precursors earlier. A positive result does not confirm a diagnosis. It identifies who needs a better test. A sound programme therefore needs a defined population, an appropriate test, a confirmation pathway and evidence of net benefit.

Spain's Ministry of Health says population programmes should demonstrate effectiveness, safety and cost-effectiveness, and that benefits must outweigh false positives, overdiagnosis and overtreatment. Spain currently has population programmes for breast, colorectal and cervical cancer, planned and delivered by its autonomous regions.

Ages and intervals change with country, region and updates to each programme. Symptoms should not wait for the next screening invitation either; they require diagnostic assessment. For US readers, the USPSTF A and B recommendations are a useful benchmark, but they do not replace local guidance or individual context.

Do general health checks work?

There is an important surprise here. A Cochrane review of randomised trials found that general health checks offered to adults did not reduce total, cardiovascular or cancer mortality. This does not make blood-pressure control, vaccination or indicated screening useless. It means that combining many tests without selecting for risk does not guarantee better outcomes.

A targeted intervention can work. Among people at high risk of diabetes, the Diabetes Prevention Program reduced diabetes incidence by 58% with an intensive lifestyle intervention over an average 2.8 years of follow-up. This was not passive testing. It identified risk, applied a concrete intervention and measured a clinical outcome.

The difference is simple: measurement is not prevention. Prevention requires data to lead to proportionate action, evidence that the action helps and follow-up to see whether it works.

How to decide whether an advanced test is worthwhile

ApoB, Lp(a), coronary calcium, DXA, glucose monitoring, VO₂ max and selected genetic tests can be useful for the right person. They do not belong to one evidence tier, and they do not need the same testing interval.

Before accepting a test, try five questions:

1. What is the question? Wanting more information is understandable, but it does not define a clinical decision.
2. What is the probability before testing? A finding means something different at low and high prior risk.
3. Is the method validated? Repeatability and reference values matter as much as the number.
4. What happens after each result? Include normal, uncertain and abnormal outcomes.
5. What harm can follow? Cost, radiation, incidental findings, anxiety and downstream procedures count.

Coronary calcium is one example. It can resolve a treatment decision for someone at intermediate cardiovascular risk, but it is not a routine scan for every young adult. The American Heart Association's PREVENT equations illustrate the right logic: integrate cardiovascular, kidney and metabolic factors before deciding whether another test could reclassify risk.

Quaternary prevention is still care

Saying “not yet” can be an excellent medical intervention. Quaternary prevention is not about saving money at the patient's expense. It protects people from cascades that begin with a low-value measurement.

A BMJ Open qualitative study identified familiar barriers: expectations of receiving a test, fear of missing something and difficulty talking about uncertainty. The answer is not to hide information. It is to share the reasoning and agree on clear signals that would trigger a review.

This is particularly helpful for epigenetic clocks, omics, whole-body MRI and broad hormone panels. They may have scientific interest or a specific indication, but a striking result alone does not prove disease, rejuvenation or a need for treatment.

What a good preventive visit should leave you with

You do not need a thicker folder when the visit ends. You need a short map:

• the two or three risks that deserve priority;
• what is already fine and does not need chasing;
• which concrete action starts now;
• which measurement will be repeated, when and why;
• which symptoms or changes should prompt an earlier review.

For bone and body composition, for example, a DXA scan only adds value when the indication and interpretation are sound. The goal is not to collect a fat or density score. It is to decide about strength, nutrition, fracture risk or treatment.

Frequently asked questions

What is preventive medicine?

It is the part of medicine that aims to prevent disease, detect it early and reduce complications. It includes habits, vaccines, screening, risk-factor control and follow-up tailored to the individual.

How is it different from a general check-up?

A check-up can be just a collection of tests. Prevention starts with age, history, symptoms and risk, then selects only measurements capable of changing a decision.

What should an adult review first?

Blood pressure, tobacco and alcohol, physical activity, sleep, mental health, vaccines, cardiometabolic risk and official screening usually come first. The exact selection depends on the country and clinical profile.

Does more testing mean better prevention?

No. In people at low risk, testing without a clear question can create false positives, anxiety and diagnostic cascades. A test adds value when its result can change treatment, follow-up or habits.

When is an advanced test worthwhile?

When there is a clinical question, prior risk justifies measurement, the result can reclassify that risk and everyone has agreed what will happen after each possible result.

Can preventive medicine stop every disease?

No. It can reduce some risks and find certain problems earlier, but it cannot remove uncertainty or guarantee that someone will not become ill.

How often should I have a preventive review?

There is no universal interval. It depends on age, previous results, medication, pregnancy, family history and risk. Some measurements are repeated soon; others are one-off or follow multi-year schedules.

Does prevention replace primary care?

No. It should be integrated with primary care and specialists who know your history. Duplicating tests across disconnected services can increase errors and confusion.

Sources

1. World Health Organization: Noncommunicable diseases. 2025.
2. Spanish Ministry of Health: cancer screening programmes. Accessed 2026.
3. USPSTF: A and B Recommendations. Accessed 2026.
4. Krogsbøll LT et al. General health checks in adults. Cochrane Database, 2019.
5. Knowler WC et al. Diabetes Prevention Program. NEJM, 2002.
6. Khan SS et al. AHA PREVENT equations. Circulation, 2024.
7. Otte JA et al. Quaternary prevention. BMJ Open, 2024.
8. López-Otín C et al. Hallmarks of aging. Cell, 2023.

This article is informational and does not replace medical assessment. Check current official vaccination and screening guidance for your age, risk and place of residence.